Compass Pathways advances U.S. rollout plans, hires incentives reported
Compass Pathways said it is advancing a potential U.S. rollout of its COMP360 psilocybin TRD and PTSD programs, with a rolling NDA targeted for H1 2027. It also granted equity to 31 new hires.
S. rollout of its COMP360 psilocybin TRD and PTSD programs through a rolling NDA targeted for H1 2027. The company also said it granted 280,600 options and 133,500 RSUs/nominal cost options to 31 new hires as part of an incentive package.